Diodes Incorporated’s DIOD share price has surged by 5.18%, which has investors questioning if this is right time to sell.

Alkermes has a huge opportunity to expand its label to include pediatric patients with Schizophrenia and bipolar I disorder.

From ‘sickness’ to ‘stability,’ the way we talk about bipolar disorder can shape how others see us — and how we see ourselves.